logo
episode-header-image
Nov 2020
32m 37s

The Vaccine: The first glimmer of hope

THE TIMES
About this episode

The first in an unfolding miniseries - The Vaccine - tracking the progress of those tackling this historic challenge. We'll be making sense of the latest developments as they happen, taking an inside look at the vaccine industry, and learning from past efforts to defend humanity from our biological enemies.


This week: in the war between scientists and the virus it looks like things are going the humans’ way. But this is no quick fix.


This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today and get one month free at: thetimes.co.uk/storiesofourtimes.


Guests: 

Tom Whipple, science editor, The Times.

Professor David Salisbury, former director of immunisation at the Department of Health. 


Host: David Aaronovitch.


Clips: CBC News, BBC Radio 4, CNBC, TRT World, BBC Radio 2.

Hosted on Acast. See acast.com/privacy for more information.

Up next
Today
The prison chief linked to organised crime - the Sunday Story
Bobby Cunningham was 31 when he became Head of Security at Wandsworth Prison, Britain’s most notorious jail, where he was tasked with fighting corruption. The Sunday Times's Whitehall editor Gabriel Pogrund reveals his dealings with organised crime.This podcast was brought to you ... Show More
38m 35s
Yesterday
Inside the Church of England's 'sex cult' - the Saturday Story
Chris Brain, the leader of a Church of England ‘sex cult’ known s the Nine O'Clock Service, has been found guilty of 17 charges of indecent assault, three decades after its collapse. Why did the Church fail to learn lessons from the scandal?This podcast was brought to you thanks ... Show More
33m 39s
Aug 22
The Brit standing up to China - can Starmer save Jimmy Lai
Pro-democracy campaigner, media mogul and British citizen Jimmy Lai has been imprisoned in China for five years and on trial for two. As the closing statements are made, what will happen to one of China’s most prominent critics? And can the UK government - or Donald Trump - step ... Show More
29m 30s
Recommended Episodes
Dec 2020
The Beginning of the End of the Pandemic
In Britain, news that the country had become the first to start administering a fully tested coronavirus vaccine was met with hope, excitement — and some trepidation.Amid the optimism that normal life might soon resume, there is also concern. Has the vaccine been developed too fa ... Show More
22m 18s
Dec 2020
Vaccino (with an extra shot)
A great day for science, a bad day for Covid-19. As the first Pfizer vaccines are given to patients in the UK, the Oxford-AstraZeneca vaccine publishes its data. Adam and Fergus chat to virologist Dr Elisabetta Groppelli about how the rollout might go - and learn some Italian whi ... Show More
31m 9s
Mar 2021
The State of Vaccinations
The United States has never undertaken a vaccination campaign of the scale and speed of the Covid-19 program. Despite a few glitches, the country appears to be on track to offer shots to all adults who want one by May 1.We look at the ups and downs in the American vaccination cam ... Show More
26m 42s
Dec 2020
Race for the Vaccine
On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ... Show More
39m 42s
Jul 2020
The Vaccine Trust Problem
Public health officials and private researchers have vowed to develop a coronavirus vaccine in record time. But could that rush backfire? Guest: Jan Hoffman, a health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily Background r ... Show More
27m 45s
Nov 2020
A Vaccine Breakthrough
It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 per ... Show More
24m 29s
Jul 2021
The Vaccine Mandate Conundrum
In the effort to raise America’s vaccination rate, some agencies and private organizations have turned to the last, and most controversial, weapon in the public health arsenal: vaccine mandates.How have the federal government and the White House approached the issue?Guest: Jennif ... Show More
22m 14s
Sep 2023
A New Covid Shot for a New Covid Era
On Tuesday afternoon, the U.S. government recommended that almost every American begin taking a new annual vaccine for Covid, a milestone in the nation’s three-year battle against the virus.Apoorva Mandavilli, a science and global health reporter for The New York Times, explains ... Show More
26m 25s
Jul 2021
Do We Need a Third Covid Shot?
The rise of the Delta variant has prompted a thorny question: Do we need a booster dose of the vaccine for Covid-19? Vaccine makers think so, but regulators are yet to be convinced.Principles are also at stake: Should richer countries be talking about administering extra doses wh ... Show More
22m 14s
Feb 2021
Kids and Covid
The end of summer 2021 has been earmarked as the time by which most American adults will be vaccinated. But still remaining is the often-overlooked question of vaccinations for children, who make up around a quarter of the U.S. population.Without the immunization of children, her ... Show More
24m 47s
Listen to millions of songs and podcasts on Anghami